pronoctan 1 mg tabletter
bayer ab - lormetazepam - tabletter - 1 mg
program vet. 40 mg injektionsvæske, suspension
elanco gmbh - lufenuron - injektionsvæske, suspension - 40 mg
program vet. 80 mg injektionsvæske, suspension
elanco gmbh - lufenuron - injektionsvæske, suspension - 80 mg
program vet. 204,9 mg filmovertrukne tabletter
elanco gmbh - lufenuron - filmovertrukne tabletter - 204,9 mg
program vet. 409,8 mg filmovertrukne tabletter
elanco gmbh - lufenuron - filmovertrukne tabletter - 409,8 mg
program vet. 67,8 mg filmovertrukne tabletter
elanco gmbh - lufenuron - filmovertrukne tabletter - 67,8 mg
program vet. 133 mg oral suspension, enkeltdosisbeholder
elanco gmbh - lufenuron - oral suspension, enkeltdosisbeholder - 133 mg
urilin 40 mg/ml syrup
dechra regulatory b.v. - phenylpropanolaminhydrochlorid - syrup - 40 mg/ml
propaline vet. til hund 50 mg/ml oral opløsning
vetoquinol s.a. - phenylpropanolaminhydrochlorid - oral opløsning - 50 mg/ml
intuniv
takeda pharmaceuticals international ag ireland branch - guanfacinhydrochlorid - attention deficit disorder med hyperaktivitet - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv skal bruges som en del af et omfattende adhd behandling program, typisk, herunder psykologiske, pædagogiske og sociale foranstaltninger.